3273F High risk prostate cancer
Also known as: high-risk prostate cancer, unfavorable-risk prostate cancer, advanced prostate cancer
Performance measure for prostate cancer classified as high-risk disease. Quality metric documenting aggressive tumor characteristics requiring intensive multimodal treatment.
Clinical Context
Quality measure for identifying high-risk prostate cancer requiring aggressive treatment with combined modality therapy including external beam radiation, brachytherapy, and/or androgen deprivation therapy.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.